Moderator: Youssuf Saleh (Oxford, United Kingdom) Guest: Sebastiaan Engelborghs (Brussel, Belgium) Youssuf Saleh interviews Prof. Sebastiaan Engelborghs on Alzheimer's biomarkers, focusing on amyloid and tau. They discuss diagnostic challenges, the need for prognostic markers, and potential serum markers like neurofilament light. Engelborghs highlights Alzheimer's complexity and the role of omics studies in patient subpopulations. The interview concludes with optimism for blood-based biomarkers revolutionizing diagnosis in the next five years, contingent on clinical validation and evolving therapies.
Fler avsnitt av eanCast: Weekly Neurology
Visa alla avsnitt av eanCast: Weekly NeurologyeanCast: Weekly Neurology med ean.org finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
